Telara pharma
WebContact – Telara Pharma. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. WebSee Telara Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on Telara Pharma's post-money valuation and revenue.
Telara pharma
Did you know?
WebApr 15, 2024 · Telara Pharma is focused on the research, development, and marketing of drugs for the treatment of high prevalence pathologies (mainly kidney injuries and … WebTelara Pharma has signed an exclusive worldwide license agreement with the Canadian company Arch Biopartners to use cilastatin in the treatment and prevention of acute kidney injury and in sepsis processes. Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the Imipenem ...
WebApr 15, 2024 · Arch Biopartners Inc. announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain (“Telara”) to clinically develop and market cilastatin, a small-molecule drug candidate for […] WebApr 15, 2024 · Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammation Novel Mechanism of Action -
WebApr 15, 2024 · Telara Pharma is focused on the research, development, and marketing of drugs for the treatment of high prevalence pathologies (mainly kidney injuries and … WebMay 10, 2024 · The company's drug is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme to prevent degradation of the Imipenem antibiotic in the kidney, enabling doctors to prevent the patients from the toxicity of other drugs and generalized infections from causing kidney damage. Contact Information Website www.telarapharma.com …
WebSolution – Telara Pharma. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies.
WebTelara Pharma raised a total of $120K. Who are the investors of Telara Pharma? Investors of Telara Pharma include Genesis Biomed and Gregorio Marañón Hospital. Who to Watch P Predictit PredictIt is a real-money political prediction market, a stock market for politics. green magic homes constructionWebApr 15, 2024 · Arch Biopartners ( OTCQB:ACHFF) announces that it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain to clinically develop … flying irishWebMay 14, 2024 · Telara Pharma Category Spain Business Description Telara Pharma S.L. is a spin-off company from the Gregorio Marañón Health Research Institute (IiSGM), … green magic homes cost 2022Web--Arch Biopartners Inc., announced today it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain to clinically develop and market cilastatin, a small-molecule drug ... flying in wrath of the lich kingWebIn addition, Telara Pharma and Hospital Gregorio Marañón will participate in the clinical development of cilastatin, led by Arch Biopartners. As part of the licensing agreement and collaboration, the Telara team will provide Arch Biopartners with safety and pharmaceutical development data originating from Phase I to support a future Phase II ... green magic homes cost 2021WebMay 11, 2024 · Thanks to the support of Genesis Biomed, Telara Pharma -a spin-off from Gregorio Marañón General University Hospital – has signed an exclusive worldwide licence agreement with the Canadian company Arch Biopartners for the use of cilastatin as treatment and prevention of acute kidney injury and sepsis processes. flying iphoneWebApr 15, 2024 · (2024-04-15 TSXV:ARCH) Arch Biopartners Enters Into Worldwide License Agreement With Telara Pharma To Re-Purpose Cilastatin For The Treatment And … flying in your second trimester